Nicholas Jason Singer, Director at Eterna Therapeutics Inc. (ERNA), bought 566,572 shares at $3.28 ($1.9M) on 2022-12-02, disclosed to the SEC on 2022-12-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.28 | 70,822 | $232K | 12.5% |
| 2 | $3.28 | 70,822 | $232K | 12.5% |
| 3 | $3.28 | 212,464 | $697K | 37.5% |
| 4 | $3.28 | 212,464 | $697K | 37.5% |
| Total | $3.28 avg | 566,572 | $1.9M | 100% |